Skip to main content
All lobbying filings

BALLARD PARTNERS

Lobbying for BIOMERIEUX, INC. · Medical technology company

 Filing 3rd Quarter - Termination
3rd Quarter (July 1 - Sep 30) 2025 · Utah · $20,000.00 income · posted Oct 16, 2025

Official filing document

 Lobbying activity 1
Health Issues

Provide advocacy on issues related to bioMerieux and in vitro diagnostics.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem